Canberra calls in a manufacturer to map out a future for the sector

By Peter Roberts The federal government has turned to former Dow chemical CEO Andrew Liveris to help map a new future for Australian manufacturing in the post-coronavirus world. Liveris, an Australian, has been called up by Canberra’s National COVID-19 Coordination Commission to devise a long-term strategy to deliver a competitive manufacturing sector to help in…

Drug companies should drop their patents and collaborate to fight coronavirus

As the coronavirus pandemic continues to claim victims around the world, the race is on to produce the right medicines to fight it. This includes developing a vaccine to stop people from falling ill in the first place, testing kits and drugs to treat those that fall ill with COVID-19.

The reinvention of Australian Industry Content and its ramifications

Australian Manufacturing Forum viewpoint by Mike Kalms Without anything really changing, Australian Industry Content Policy (AICP) is now unalterably different. There have been relatively cosmetic changes to how AICP is described, at what thresholds it applies, and how it might be measured, but none of these constitute wholesale change or any sort of ‘policy re-write’.…